J. Wunderlich

Immunology · Science · 2002–2016

A researcher in the Science corpus: 15 papers; trusts 1 researcher and is trusted by 4 researchers here, as inferred from the citation graph.

Subfields

• Immunology — 94 citations into it; #1,086 of 2,160 by trust here, #179 by citations
• Oncology — 91 citations into it; #683 of 1,698 by trust here, #101 by citations

Whom J. Wunderlich trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. S. Rosenberg

Who trusts J. Wunderlich overall

1. S. Rosenberg
2. M. Dudley
3. W. Zou

Papers from J. Wunderlich's perspective

Ordered by how strongly the researchers J. Wunderlich trusts endorse each paper. Same corpus, a different order for every researcher.

1. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. (Science)
2. Coregulation of CD8+ T cell exhaustion during chronic viral infection by multiple inhibitory receptors (Nature Immunology)
3. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer (New England Journal of Medicine)
4. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction (Nature Medicine)
5. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
6. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity (Journal of Experimental Medicine)
7. T cell exhaustion (Nature Immunology)
8. The role of TNF superfamily members in T-cell function and diseases (Nature reviews. Immunology)
9. Exhaustion of tumor-specific CD8⁺ T cells in metastases from melanoma patients. (Journal of Clinical Investigation)
10. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. (Immunity)

Their papers

• Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. (2011) — 1,605 citations
• Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients (2016) — 809 citations
• Immunogenicity of somatic mutations in human gastrointestinal cancers (2015) — 702 citations
• PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors. (2014) — 994 citations
• A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T cell receptor: Long term follow up and correlates with response (2014) — 728 citations
• Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer (2014) — 1,637 citations
• Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T Cell Transfer Immunotherapy (2011) — 1,972 citations
• Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. (2009) — 1,438 citations
• Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. (2009) — 1,711 citations
• Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens (2008) — 1,357 citations
• A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer (2006) — 1,238 citations
• Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes (2006) — 2,728 citations
• Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. (2005) — 1,709 citations
• Generation of Tumor-Infiltrating Lymphocyte Cultures for Use in Adoptive Transfer Therapy for Melanoma Patients (2003) — 702 citations
• Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes (2002) — 3,012 citations